Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Hitachi (Sweden) | Researchclopedia

Back to institutions

Hitachi (Sweden)

Västeråscompany

323

Works

3,177

Citations

28

h-index

Top Research Topics

HVDC Systems and Fault Protection Microgrid Control and Optimization Islanding Detection in Power Systems

Top Researchers

Ye Li East China Normal University

939 works16,181 citationsh-index: 57

Recent Research

WCN26-8197 BUDESONIDE MODULATES B- AND T-CELL IMMUNITY IN PEYER'S PATCHES: IMPLICATIONS FOR IgA NEPHROPATHY

Roza Ghotbi,Jens Kristensen,et al.

20260 citations

Power System Optimization and Stability

Power Systems Fault Detection

High voltage insulation and dielectric phenomena

Silicon Carbide Semiconductor Technologies

Power Transformer Diagnostics and Insulation

High-Voltage Power Transmission Systems

Thermal Analysis in Power Transmission

Multilevel Inverters and Converters

Advanced DC-DC Converters

Jianping Wang Tongji University

935 works14,785 citationsh-index: 54

Jürgen Häfner Hitachi (Sweden)

148 works14,175 citationsh-index: 49

Jianping Wang Beijing Normal University

562 works14,092 citationsh-index: 60

Hans‐Peter Nee KTH Royal Institute of Technology

310 works13,293 citationsh-index: 53

Provas Kumar Roy KIIT University

374 works8,630 citationsh-index: 52

WCN26-8040 IMPACT OF TREATMENT WITH NEFECON ON SERUM BIOMARKERS OF GUT-ASSOCIATED LYMPHOID TISSUE FUNCTION IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY FROM THE PHASE 3 NEFIGARD TRIAL

Nadia Nawaz,Amal A.A. Jama,et al.

20260 citations

WCN26-8170 Urine protein–creatinine ratio response at 12 months in patients with immunoglobulin A nephropathy receiving nefecon vs placebo: Analysis of NefIgArd trial data

Jonathan Barratt,Heather N. Reich,et al.

20260 citations

WCN26-8313 ABSOLUTE PROTEINURIA OVER TIME WITH NEFECON VS PLACEBO IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY: RESULTS FROM THE PHASE 3 NEFIGARD TRIAL

Heather N. Reich,B.H. Rovin,et al.

20260 citations

WCN26-6463 SAFETY AND PRELIMINARY EFFICACY FINDINGS FROM A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SETANAXIB IN PATIENTS WITH ALPORT SYNDROME

Daniel P. Gale,Irene Agraz Pamplona,et al.

20260 citations

WCN26-8113 THE CREATION AND INITIAL DEMOGRAPHICS OF THE PERFORM™ PATIENT REGISTRY: A NOVEL REAL-WORLD REGISTRY OF PATIENTS TREATED FOR IgA NEPHROPATHY IN THE UNITED STATES

Anna White,Russell Jones,et al.

20260 citations